{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T19:48:38Z","timestamp":1766173718279,"version":"3.48.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":332,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K12003"],"award-info":[{"award-number":["JP25K12003"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.ctarc.2025.101049","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:08:50Z","timestamp":1764432530000},"page":"101049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neoadjuvant FOLFOXIRI for locally advanced rectal cancer: A retrospective analysis focusing on long-term anal preservation"],"prefix":"10.1016","volume":"45","author":[{"given":"Ryohei","family":"Shoji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5133-2644","authenticated-orcid":false,"given":"Fuminori","family":"Teraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Matsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Kanaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunitoshi","family":"Shigeyasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ctarc.2025.101049_bib0001","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.annonc.2025.05.528","article-title":"Localised rectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"36","author":"Hofheinz","year":"2025","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2025.101049_bib0002","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial","volume":"12","author":"van Gijn","year":"2011","journal-title":"Lancet Oncol."},{"issue":"16","key":"10.1016\/j.ctarc.2025.101049_bib0003","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years","volume":"30","author":"Sauer","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2025.101049_bib0004","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S1470-2045(15)00159-X","article-title":"Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO\/ARO\/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial","volume":"16","author":"Rodel","year":"2015","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2025.101049_bib0005","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/SLA.0000000000005780","article-title":"Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): initial results of a phase III trial","volume":"277","author":"Mei","year":"2023","journal-title":"Ann. Surg."},{"issue":"27","key":"10.1016\/j.ctarc.2025.101049_bib0006","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1200\/JCO.2016.66.6198","article-title":"Modified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer: initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm Phase III trial","volume":"34","author":"Deng","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2025.101049_bib0007","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa2303269","article-title":"Preoperative treatment of locally advanced rectal cancer","volume":"389","author":"Schrag","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101049_bib0008","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12885-020-07766-5","article-title":"Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)","volume":"21","author":"Miwa","year":"2021","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.ctarc.2025.101049_bib0009","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/jjco\/hyt115","article-title":"Neoadjuvant oxaliplatin and capecitabine and bevacizumab without radiotherapy for poor-risk rectal cancer: N-SOG 03 Phase II trial","volume":"43","author":"Uehara","year":"2013","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101049_bib0010","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1186\/s12885-023-11103-x","article-title":"Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer to transform effectively EMVI and MRF from positive to negative: results of a long-term single center phase 2 clinical trial","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2025.101049_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","article-title":"Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer","volume":"25","author":"Hashiguchi","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101049_bib0012","first-page":"1","article-title":"Quality of life after radiotherapy for rectal and anal cancer","volume":"16","author":"Neibart","year":"2020","journal-title":"Curr. Colorectal. Cancer Rep."},{"issue":"3","key":"10.1016\/j.ctarc.2025.101049_bib0013","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/cancers15030778","article-title":"Management of low anterior resection syndrome (LARS) following resection for rectal cancer","volume":"15","author":"Rosen","year":"2023","journal-title":"Cancers. (Basel)"},{"issue":"4","key":"10.1016\/j.ctarc.2025.101049_bib0014","doi-asserted-by":"crossref","first-page":"175","DOI":"10.23922\/jarc.2019-018","article-title":"Japanese classification of colorectal, appendiceal, and anal carcinoma: the 3d English edition [Secondary Publication]","volume":"3","year":"2019","journal-title":"J. Anus. Rectum. Colon"},{"issue":"2","key":"10.1016\/j.ctarc.2025.101049_bib0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ctarc.2025.101049_bib0016","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.radonc.2020.03.011","article-title":"Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - results of the international randomized RAPIDO-trial","volume":"147","author":"van der Valk","year":"2020","journal-title":"RadiOther Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2025.101049_bib0017","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann. Surg."},{"issue":"2","key":"10.1016\/j.ctarc.2025.101049_bib0018","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(15)00467-2","article-title":"Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis","volume":"17","author":"Renehan","year":"2016","journal-title":"Lancet Oncol."},{"issue":"23","key":"10.1016\/j.ctarc.2025.101049_bib0019","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.3390\/cancers16234005","article-title":"Long-term effects on gonadal function after treatment of colorectal cancer: a systematic review and meta-analysis","volume":"16","author":"Anthon","year":"2024","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ctarc.2025.101049_bib0020","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.sla.0000183608.24549.68","article-title":"Adjuvant radiotherapy is associated with increased sexual dysfunction in male patients undergoing resection for rectal cancer: a predictive model","volume":"242","author":"Heriot","year":"2005","journal-title":"Ann. Surg."},{"issue":"3","key":"10.1016\/j.ctarc.2025.101049_bib0021","first-page":"240","article-title":"Capecitabine and oxaliplatin prior and concurrent to preoperative pelvic radiotherapy in patients with locally advanced rectal cancer: long-term outcome","volume":"16","author":"Hess","year":"2017","journal-title":"Clin. Colorectal. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2025.101049_bib0022","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/DCR.0b013e31819739a0","article-title":"Analysis of clinical factors associated with anal function after intersphincteric resection for very low rectal cancer","volume":"52","author":"Ito","year":"2009","journal-title":"Dis. Colon Rectum"},{"issue":"5","key":"10.1016\/j.ctarc.2025.101049_bib0023","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.2009.25.8541","volume":"28","author":"Fernandez-Martos","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.ctarc.2025.101049_bib0024","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1200\/JCO.21.01667","article-title":"Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR)","volume":"40","author":"Jin","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2025.101049_bib0025","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.3390\/cancers15092567","article-title":"Selecting a TNT schedule in locally advanced rectal cancer: can we predict who actually benefits?","volume":"15","author":"Aschele","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctarc.2025.101049_bib0026","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2025.101049_bib0027","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2025.101049_bib0028","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.4103\/jcrt.jcrt_1207_22","article-title":"mFOLFOX4 with or without radiation in neoadjuvant treatment of locally advanced middle and low rectal cancer","volume":"18","author":"Yan","year":"2022","journal-title":"J. Cancer Res. Ther."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101049_bib0029","doi-asserted-by":"crossref","first-page":"24","DOI":"10.23922\/jarc.2021-033","article-title":"Feasibility and efficacy of Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer","volume":"6","author":"Tokuhara","year":"2022","journal-title":"J. Anus. Rectum. Colon."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101049_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102514","article-title":"Induction triplet chemotherapy in patients with rectal adenocarcinoma and synchronous metastases, an AGEO-FFCD study","volume":"49","author":"Dabout","year":"2025","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"9","key":"10.1016\/j.ctarc.2025.101049_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e00804","article-title":"BACCHUS: a randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)","volume":"4","author":"Glynne-Jones","year":"2018","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.ctarc.2025.101049_bib0032","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/GIM.0b013e31818efd77","article-title":"Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review","volume":"11","author":"Palomaki","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.ctarc.2025.101049_bib0033","first-page":"61","article-title":"UGT1A1 polymorphisms in cancer: impact on irinotecan treatment","volume":"10","author":"Takano","year":"2017","journal-title":"Pharmgenom. Pers. Med."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T19:44:49Z","timestamp":1766173489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294225001856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":33,"alternative-id":["S2468294225001856"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101049","relation":{},"ISSN":["2468-2942"],"issn-type":[{"type":"print","value":"2468-2942"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant FOLFOXIRI for locally advanced rectal cancer: A retrospective analysis focusing on long-term anal preservation","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101049"}}